<DOC>
	<DOCNO>NCT01973881</DOCNO>
	<brief_summary>This study development validation functional magnetic resonance imaging ( MRI ) parameters biomarkers analyze extent disease quantify response treatment patient myelofibrosis .</brief_summary>
	<brief_title>Quantitative MRI Myelofibrosis</brief_title>
	<detailed_description>This study development validation functional magnetic resonance imaging ( MRI ) parameters biomarkers analyze extent disease quantify response treatment patient myelofibrosis . Quantitative MRI parameter diffusion water and/or fat content bone marrow determine extent disease patient myelofibrosis , change parameter predict response therapy . To investigate hypothesis , researcher perform pilot clinical study diffusion fat content ( T1 weight image ) patient treatment myelofibrosis . The researcher expect identify MRI parameter determine extent severity bone marrow disease patient determine response therapy early time point currently use clinical parameter . This research lay foundation large clinical trial use MRI ass predict effect exist new therapeutic agent patient myelofibrosis . This study propose advanced MRI technique currently use clinical medicine apply enable response therapy determine earlier currently possible patient myelofibrosis . In particular , study design determine extent abnormality diffusion water molecule ( diffusion MRI ) and/or fat content bone marrow ( T1-weighted imaging ) define extent initial disease serve early predictor response therapy .</detailed_description>
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<criteria>1 . Male /female subject age 18 2 . Diagnosis primary myelofibrosis , postpolycythemia vera myelofibrosis , postessential thrombocythemia myelofibrosis . 3 . No contraindication MRI 4 . Able undergo MRI without anesthesia 1 . Patients pacemaker implant magnetic device may malfunction move strong magnetic field inside MRI room scanner . 2 . Any prior adverse event associate MRI related injection contrast agent medicine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>